-
41.
公开(公告)号:SI1317413T1
公开(公告)日:2005-12-31
申请号:SI200130413
申请日:2001-07-16
Applicant: SERVIER LAB
Inventor: DESCAMPS-FRANCOIS CAROLE , YOUS SAID , LESIEUR DANIEL , GUILLAUMET GERALD , VIAUD MARIE-CLAUDE , DA COSTA HERVE , BENNEJEAN CAROLINE , DELAGRANGE PHILIPPE , RENARD PIERRE
IPC: C07C233/00 , A61K31/00 , C07C209/00 , C07D307/00 , C07D333/00 , C07D471/00
-
公开(公告)号:AR044996A1
公开(公告)日:2005-10-12
申请号:ARP040102337
申请日:2004-07-02
Applicant: SERVIER LAB
Inventor: MESANGEAU CRISTOPHE , LESIEUR DANIEL , BENNEJEAN CAROLINE , BOUTIN JEAN-ALBERT , AUDINOT VALERIE , DELAGRANGE PHILIPPE , RENARD PIERRE , YOUS SAID
IPC: A61P3/10 , A61P15/00 , A61P25/00 , A61P25/20 , C07D333/62 , A61K31/381
Abstract: Reivindicación 1: Compuestos de fórmula (1), en la cual: R1 representa un átomo de halógeno, un grupo alquilo (C1-6) lineal o ramificado o un grupo alcoxi (C1-6) lineal o ramificado; R2 representa un grupo fenilo no sustituido o sustituido por uno a tres grupos elegidos entre hidroxi, alquilo (C1-6) lineal o ramificado, alcoxi (C1-6) lineal o ramificado, carboxi, formilo, nitro, ciano, polihalogenoalquilo (C1-6) lineal o ramificado o átomos de halógeno; R3 representa un grupo alquilo (C1-6) lineal o ramificado sustituido o no sustituido, alquenilo (C1-6) lineal o ramificado no sustituido o sustituido, cicloalquilo (C3-8) o cicloalquil(C3-8)alquilo(C1-6) en el cual la parte alquilo puede ser lineal o ramificada, y se entiende que: el término "sustituido" aplicado a "alquilo" y "alquenilo" indica que estos grupos están sustituidos por uno o más átomos de halógeno, o por uno o más grupos elegidos entre hidroxi o alcoxi (C1-6) lineal o ramificado, sus enantiómeros y diastereoisómeros, así como también sus sales de adición con un ácido o con una base farmacéuticamente aceptable.
-
43.
公开(公告)号:EA005766B1
公开(公告)日:2005-06-30
申请号:EA200300376
申请日:2001-07-16
Applicant: SERVIER LAB
Inventor: DESCAMPS-FRANCOIS CAROLE , YOUS SAID , LESIEUR DANIEL , GUILLAUMET GERARLD , VIAUD MARIE-CLAUDE , DA COSTA HERVE , BENNEJEAN CAROLINE , DELAGRANGE PHILIPPE , RENARD PIERRE
IPC: C07D333/58 , A61K31/235 , A61K31/343 , A61K31/381 , A61K31/4045 , A61K31/437 , A61P3/04 , A61P3/10 , A61P15/00 , A61P25/00 , A61P25/04 , A61P25/16 , A61P25/20 , A61P25/28 , A61P35/00 , C07C231/12 , C07C233/18 , C07C233/60 , C07D209/08 , C07D209/20 , C07D307/68 , C07D307/79 , C07D307/81 , C07D333/54 , C07D471/04 , C07C209/16 , A61K31/165 , A61K31/335 , A61K31/38 , A61K31/40
Abstract: Изобретениеотноситсяк соединениямформулы (I)вкоторойВ обозначаетатомводорода, COOR группу, CONRR' группуили (С-С)алкильнуюгруппу, замещенную COOR, CONRR' или OR группой,Gобозначает -X'-(CH)-X-(CH)-X"-цепь, вкоторой X, X", X", n и m принимаютзначения, указанныев описании,Суобозначаетгруппуформулы (II) или (III)Gобозначаеталкиленовуюцепь, такую, какуказанов описании,иА обозначает NRCOR', NRCSR', CONRR', CSNRR', NRCONR'R" или NRCSNR'R" группу.Медикаменты.
-
公开(公告)号:MA27409A1
公开(公告)日:2005-06-01
申请号:MA28231
申请日:2005-04-19
Applicant: SERVIER LAB
Inventor: POISSONNIER-DURIEUX SOPHIE , YOUS SAID , LESIEUR DANIEL , BENNEJEAN CAROLINE , DELAGRANGE PHILIPPE , RENARD PIERRE
IPC: A61P1/00 , A61P3/00 , A61P3/04 , A61P3/10 , A61P9/10 , A61P15/18 , A61P25/00 , A61P35/00 , A61P37/02 , C07C233/18 , C07C233/36 , C07C233/60 , C07D207/26 , C07D207/27 , A61K31/16
-
公开(公告)号:NO318113B1
公开(公告)日:2005-01-31
申请号:NO986045
申请日:1998-12-22
Applicant: SERVIER LAB
Inventor: LESIEUR DANIEL , DELAGRANGE PHILIPPE , BENNEJEAN CAROLINE , RUIZ NICOLAS , WALLEZ VALERIE , BOYE SOPHIE , RENARD PIERRE
IPC: A61K31/00 , A61K31/34 , A61K31/343 , A61K31/35 , A61K31/352 , A61K31/38 , A61K31/381 , A61K31/44 , A61K31/4427 , A61K31/443 , A61K31/4433 , A61P3/00 , A61P3/04 , A61P3/10 , A61P9/00 , A61P9/06 , A61P25/00 , A61P25/04 , A61P25/18 , A61P25/20 , A61P25/28 , A61P43/00 , C07D307/79 , C07D307/81 , C07D307/82 , C07D333/54 , C07D333/58 , C07D333/60 , C07D333/62 , C07D405/06 , C07D405/12 , C07D407/04 , C07D409/06 , C07D409/12 , C07D493/04 , C07D495/04 , C07D307/78 , C07D333/52
Abstract: Benzofuryl and benzothienyl alkyl amides (I), their enantiomers, diastereoisomers, and salts with acids and bases are new. The benzofuryl and benzothienyl derivatives (I) are new: a = saturated or unsaturated bond; W' = O or S; B' = 1-6C alkylene (optionally substituted by one or more 1-6C alkyl, 1-6C alkoxy, OH, carboxy, and/or 1-6C alkoxy carbonyl); R = H, OH, R', or OR'; R' = 1-6C alkyl or trihaloalkyl sulfonyl, 2-6C alkenyl or alkynyl, 3-7C cycloalkyl, aryl, biphenyl, or heteroaryl (all optionally substituted); either G1 = halogen, 1-6C trihaloalkyl sulfonyloxy, COOH, CHO, CN, R1, -CO-R1, or -O-CO-R1; R1 = 1-6C alkyl, 2-6C alkenyl or alkynyl, 3-7C cycloalkyl, aryl, biphenyl or heteroaryl (all optionally substituted); when G11 = H or; G11+R = 5-7C saturated or unsaturated oxygen-containing ring (optionally substituted by 1-6C alkyl, 1-6C alkoxy, OH, oxo, COOH, or 1-6C alkoxycarbonyl) or G1 = H; when G11 = 1-6C trihaloalkyl sulfonyloxy, COOH, CHO, CN, R1, -CO-R1, or -O-CO-R1; G2 = (i), (ii), or (iii); X = O or S; R2 = H or 1-6C alkyl; R20 - R22 = 1-6C alkyl, 2-6C alkenyl or alkynyl, 3-7C cycloalkyl, aryl, biphenyl, or heteroaryl (all optionally substituted) provided that: when G2 = (iii) in which R22 is not aryl, heteroaryl or biphenyl, then G1 or G11 is heteroaryl other than pyridyl, 1-6C alkyl, 1-6C alkylheteroaryl (other than pyridyl), COR1, or O-CO-R1; when G2 = (i) or (ii) in which R20 and R21 are not aryl, biphenyl or heteroaryl, and G1 is other than heteroaryl or naphthyl, and R is H, then B' is a methylene or ethylene chain (optionally substituted); when G2 = (i) or (ii) in which R20 and R21 are not aryl, or heteroaryl, and when R and G1 are both H, then G11 is other than 1-6C alkyl, 3-7C cycloalkyl (optionally substituted by halogen, OH) or 1-6C alkyl (optionally substituted by halogen, OH or 1-6C alkoxy or 3-7C cycloalkyl (optionally substituted by halogen or OH)); when G2 = (i) or (ii) in which R20 and R21 are not aryl, or heteroaryl, and G1 is H and R is OR', R' being other than heteroaryl, then G11 is other than 1-6C alkyl, 2-6C alkenyl, or 2-6C alkynyl; when G2 = either (ii) with R21 being other than 2-6C alkenyl or alkynyl or (i) with R20 being cycloalkyl (optionally substituted by halogens), OH, 1-6C alkoxy, or 1-6C alkyl (optionally substituted by 3-7C cycloalkyl (optionally substituted by halogens, OH or 1-6C alkoxy), then G11 is other than 1-6C alkyl, and G1 is other than halogen, 1-6C alkyl, 1-6C alkylphenyl, or phenyl; and when G2 = (ii), X is S and B' is ethylene, then R21 is other than aryl; aryl = phenyl or naphthyl; heteroaryl = mono or bicyclic (optionally substituted). An Independent claim is also included for the preparation of (I).
-
公开(公告)号:NO20041313A
公开(公告)日:2004-10-11
申请号:NO20041313
申请日:2004-03-30
Applicant: SERVIER LAB
Inventor: LESIEUR DANIEL , AUDINOT VALERIE , BENNEJEAN CAROLINE , WALLEZ VALERIE , RENARD PIERRE , YOUS SAID , DELAGRANGE PHILIPPE , POISSONNIER-DURIEUX SOPHIE , GASNEREAU ANNE , BOUTON JEAN ALBERT
IPC: C07D217/14 , A61K31/472 , A61P1/00 , A61P3/02 , A61P3/04 , A61P3/10 , A61P9/00 , A61P15/00 , A61P25/00 , A61P25/02 , A61P25/06 , A61P25/08 , A61P25/16 , A61P25/20 , A61P25/22 , A61P25/24 , A61P25/28 , A61P35/00 , A61P37/02 , A61P43/00 , C07D217/16 , C07D217/24 , C07D217/22 , A61K31/4353
CPC classification number: C07D217/16
-
公开(公告)号:ES2201029T3
公开(公告)日:2004-03-16
申请号:ES01904021
申请日:2001-02-01
Applicant: SERVIER LAB
Inventor: LESIEUR DANIEL , BLANC-DELMAS ELODIE , YOUS SAID , DEPREUX PATRICK , GUILLAUMET GERALD , DACQUET CATHERINE
IPC: A61K31/423 , A61K31/428 , A61K31/437 , A61K31/4439 , A61P1/00 , A61P1/04 , A61P1/14 , A61P1/18 , A61P3/04 , A61P3/06 , A61P3/10 , A61P5/00 , A61P9/00 , A61P9/10 , A61P9/14 , A61P13/00 , A61P13/12 , A61P15/00 , A61P17/06 , A61P19/10 , A61P21/00 , A61P21/04 , A61P25/28 , A61P35/00 , A61P43/00 , C07B61/00 , C07D263/58 , C07D277/68 , C07D417/06 , C07D471/04 , C07D498/04 , A61K31/4353
Abstract: Compounds of formula (I): wherein: X represents an oxygen or a sulphur or CH 2 or R 1 and R 2 represent a hydrogen atom, or a group as defined in the description, A represents an alkylene chain as described in the description, B is as defined in the description, R 3 and R 4 represent a hydrogen atom or a group as defined in the description, D represents an optionally substituted benzene, optionally substituted pyrazine, optionally substituted pyrimidine or optionally substituted pyridazine and medicinal products containing the same which are useful in treating or preventing melatoninergic disorders.
-
48.
公开(公告)号:ZA200205599B
公开(公告)日:2003-12-01
申请号:ZA200205599
申请日:2002-07-12
Applicant: SERVIER LAB
Inventor: LESIEUR DANIEL , BLANC-DELMAS ELODIE , YOUS SAID , DEPREUX PATRICK , GUILLAUMET GERALD , DACQUET CATHERINE , LEVENS NIGEL , BOUTIN JEAN ALBERT , BENNEJEAN CAROLINE , RENARD PIERRE
IPC: A61K31/423 , A61K31/428 , A61K31/437 , A61K31/4439 , A61P1/00 , A61P1/04 , A61P1/14 , A61P1/18 , A61P3/04 , A61P3/06 , A61P3/10 , A61P5/00 , A61P9/00 , A61P9/10 , A61P9/14 , A61P13/00 , A61P13/12 , A61P15/00 , A61P17/06 , A61P19/10 , A61P21/00 , A61P21/04 , A61P25/28 , A61P35/00 , A61P43/00 , C07B61/00 , C07D263/58 , C07D277/68 , C07D417/06 , C07D471/04 , C07D498/04 , C07D , A61K , A61P
Abstract: Compounds of formula (I): wherein: X represents an oxygen or a sulphur or CH 2 or R 1 and R 2 represent a hydrogen atom, or a group as defined in the description, A represents an alkylene chain as described in the description, B is as defined in the description, R 3 and R 4 represent a hydrogen atom or a group as defined in the description, D represents an optionally substituted benzene, optionally substituted pyrazine, optionally substituted pyrimidine or optionally substituted pyridazine and medicinal products containing the same which are useful in treating or preventing melatoninergic disorders.
-
49.
公开(公告)号:SI1252150T1
公开(公告)日:2003-10-31
申请号:SI200130014
申请日:2001-02-01
Applicant: SERVIER LAB
Inventor: LESIEUR DANIEL , BLANC-DELMAS ELODIE , YOUS SAID , DEPREUX PATRICK , GUILLAUMET GERALD , DACQUET CATHERINE , LEVENS NIGEL , BOUTIN JEAN ALBERT , BENNEJEAN CAROLINE , RENARD PIERRE
IPC: A61K31/423 , A61K31/428 , A61K31/4353 , A61P3/06 , A61P3/10 , C07D263/58 , C07D277/68 , C07D417/06 , C07D471/04 , C07D498/04
-
公开(公告)号:AR030048A1
公开(公告)日:2003-08-13
申请号:ARP010100496
申请日:2001-02-02
Applicant: SERVIER LAB
Inventor: LESIEUR DANIEL , BLANC DELMAS ELODIE , YOUS SAID , DEPREUX PATRICK , GUILLAUME D , DACQUET CATHERINE , LEVENS NIGEL , BOUTIN JEAN ALBERT , BENNEJEAN CAROLINE , RENARD PIERRE
IPC: A61K31/423 , A61K31/428 , A61K31/437 , A61K31/4439 , A61P1/00 , A61P1/04 , A61P1/14 , A61P1/18 , A61P3/04 , A61P3/06 , A61P3/10 , A61P5/00 , A61P9/00 , A61P9/10 , A61P9/14 , A61P13/00 , A61P13/12 , A61P15/00 , A61P17/06 , A61P19/10 , A61P21/00 , A61P21/04 , A61P25/28 , A61P35/00 , A61P43/00 , C07B61/00 , C07D263/58 , C07D277/68 , C07D417/06 , C07D471/04 , C07D498/04 , A61K31/4353
Abstract: Derivados heterocíclicos de formula 1 en la cual A, B, D, X, R1, R2, R3 y R4 son tal como se definen en la descripcion, sus enantiomeros y diastereoisomeros así como sus sales de adicion con un ácido o con una base farmacéuticamente aceptables; procedimiento para prepararlos y composiciones farmacéuticas que los contienen. Los derivados heterocíclicos de formula 1 son utiles para el tratamiento y/o la profilaxis de la hiperglucemias, de las dislipidemias y más particularmente en el tratamiento de las diabetes no insulinodependientes del tipo II, de la resistencia a la insulina, de la tolerancia a la glucosa, de los desordenes relacionados con el síndrome X, de las enfermedades arteriales coronarias y otras enfermedades cardiovasculares, de las enfermedades renales, de las retinopatías, de los desordenes relacionados con la activacion de las células endoteliales, de la psoriasis, del síndrome poliquístico de ovario, de la demencia, de la osteoporosis, de las enfermedades inflamatorias intestinales, de las distrofias miotonicas, de las pancreatitis, de la arterioesclerosis, del xantoma, pero también en el tratamiento o la prevencion de la diabetes de tipo I, de la obesidad, de la regulacion del apetito, de la anorexia, de la bulimia, de la anorexia nerviosa, así como de las patologías cancerosas y en especial de los cánceres hormonodependientes tales como el cáncer de pecho y el cáncer de colon, y como inhibidores de angiogénesis.
-
-
-
-
-
-
-
-
-